Combining proteasome inhibitors with autophagy inhibitors disrupts acute myeloid leukemia (AML) cells' proteostasis, enhancing treatment efficacy and inducing programmed cell death. The novel therapy ...
Medical Xpress on MSN
Scientists reveal splicing-based mechanism driving therapy resistance in pediatric acute myeloid leukemia
Pediatric acute myeloid leukemia (AML) is one of the most common acute leukemias in children. While treatment outcomes have improved in recent years, approximately 30% of patients relapse following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results